Sylvie Freeman

Publications

  1. 2020
  2. E-pub ahead of print
  3. E-pub ahead of print
  4. E-pub ahead of print
  5. E-pub ahead of print
  6. Published
  7. E-pub ahead of print
  8. Published

    Molecular MRD status and outcome after transplantation in NPM1-mutated AML

    Robert Hills, Sylvie Freeman & 19 others, , Igor Novitzky Basso, 27 Feb 2020, In: Blood. 135, 9, p. 680-688 9 p.

    Research output: Contribution to journalArticlepeer-review

  9. 2019
  10. Published

    MRD evaluation of AML in clinical practice: are we there yet?

    Sylvie Freeman, 6 Dec 2019, In: Hematology. 2019, 1, p. 557-569

    Research output: Contribution to journalArticlepeer-review

  11. Published

    Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia

    Sylvie Freeman, 22 Oct 2019, In: Blood Advances. 3, 20, p. 3052-3061 10 p.

    Research output: Contribution to journalArticlepeer-review

  12. Published

    Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML

    Sylvie Freeman & 4 others, , 1 Apr 2019, In: The Journal of Experimental Medicine. 216, 4, p. 966-981 16 p.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 3 4 5 Next